CICCIA, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 16.575
EU - Europa 7.769
AS - Asia 6.412
Continente sconosciuto - Info sul continente non disponibili 1.164
SA - Sud America 1.059
AF - Africa 158
OC - Oceania 37
Totale 33.174
Nazione #
US - Stati Uniti d'America 16.276
SG - Singapore 2.325
RU - Federazione Russa 1.983
IT - Italia 1.873
CN - Cina 1.747
BR - Brasile 849
DE - Germania 843
FI - Finlandia 800
HK - Hong Kong 689
VN - Vietnam 563
UA - Ucraina 414
PL - Polonia 407
GB - Regno Unito 354
FR - Francia 313
IE - Irlanda 248
JP - Giappone 211
BD - Bangladesh 202
SE - Svezia 149
CA - Canada 146
KR - Corea 142
IN - India 128
NL - Olanda 79
RO - Romania 73
AR - Argentina 64
MX - Messico 63
TR - Turchia 58
IQ - Iraq 57
ES - Italia 43
BE - Belgio 41
ZA - Sudafrica 39
AT - Austria 34
ID - Indonesia 33
AU - Australia 31
CO - Colombia 30
EC - Ecuador 27
PK - Pakistan 27
CH - Svizzera 25
VE - Venezuela 25
EG - Egitto 23
UZ - Uzbekistan 23
CL - Cile 21
AE - Emirati Arabi Uniti 19
PH - Filippine 19
PY - Paraguay 19
IR - Iran 18
MY - Malesia 18
CZ - Repubblica Ceca 17
JO - Giordania 17
SA - Arabia Saudita 17
KE - Kenya 16
CR - Costa Rica 15
MA - Marocco 15
CI - Costa d'Avorio 14
DZ - Algeria 14
NP - Nepal 14
GR - Grecia 13
LB - Libano 12
LT - Lituania 12
HN - Honduras 11
JM - Giamaica 11
AZ - Azerbaigian 10
BO - Bolivia 10
PA - Panama 10
TW - Taiwan 10
IL - Israele 9
TN - Tunisia 9
GE - Georgia 8
KG - Kirghizistan 8
ET - Etiopia 7
PT - Portogallo 7
DK - Danimarca 6
KZ - Kazakistan 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
PE - Perù 6
UY - Uruguay 6
PR - Porto Rico 5
SN - Senegal 5
SV - El Salvador 5
AL - Albania 4
BG - Bulgaria 4
BY - Bielorussia 4
DO - Repubblica Dominicana 4
EU - Europa 4
GT - Guatemala 4
MD - Moldavia 4
OM - Oman 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BB - Barbados 3
HR - Croazia 3
MU - Mauritius 3
PS - Palestinian Territory 3
RS - Serbia 3
AI - Anguilla 2
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
DM - Dominica 2
Totale 31.975
Città #
Fairfield 1.914
Ashburn 1.904
Singapore 1.641
Woodbridge 984
San Jose 955
Seattle 819
Chandler 773
Wilmington 761
Houston 709
Hong Kong 644
Cambridge 612
Ann Arbor 513
Moscow 389
Zgierz 356
Secaucus 343
Palermo 315
Los Angeles 301
Des Moines 292
Beijing 276
Council Bluffs 276
Helsinki 253
Medford 251
Dublin 246
Santa Clara 237
Dallas 220
Jacksonville 205
New York 195
Tokyo 195
Ho Chi Minh City 178
Chicago 175
Nanjing 167
Altamura 162
Lauterbourg 162
Princeton 161
Hefei 149
Frankfurt am Main 142
San Diego 137
Hanoi 135
Boardman 131
Lawrence 124
The Dalles 115
Milan 114
Jinan 90
Dearborn 83
Buffalo 80
Rome 76
Shenyang 69
São Paulo 64
Ludwigshafen am Rhein 63
Tulsa 60
Nanchang 59
London 54
Phoenix 51
Seoul 47
Tianjin 46
Changsha 45
Hebei 45
Toronto 43
Zhengzhou 43
Warsaw 42
Brussels 40
Orem 39
Jiaxing 36
Da Nang 35
Guangzhou 34
Columbus 33
Amsterdam 32
Seongnam 31
Ningbo 30
Bologna 29
Boston 29
Munich 29
Atlanta 28
Brooklyn 28
Johannesburg 28
Montreal 28
Rio de Janeiro 28
Salt Lake City 28
Naples 26
Falls Church 24
Haiphong 24
Kumar 24
San Paolo di Civitate 24
Baghdad 23
Denver 23
Poplar 23
Venice 23
Saint Petersburg 22
Hangzhou 20
Nuremberg 20
Pune 20
Belo Horizonte 19
Central 19
Manchester 19
North Bergen 19
Stockholm 19
Taizhou 19
Verona 19
Kilburn 18
Ottawa 18
Totale 20.721
Nome #
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis 1.089
Malattia di KiKuchi-Fujimoto e lupus eritematoso sistemico: quale connessione ?. 523
Intestinal Involvement in Kawasaki Disease 348
Ectopic expression of CXCL13, BAFF, APRIL and LT-ß is associated with artery tertiary lymphoid organs in giant cell arteritis 322
Arterial stiffness indexes and serum cytokine levels in seronegative spondyloarthritis: relationships between stiffness markers and metabolic and immunoinflammatory variables 300
One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs 299
Expansion of intestinal CD4+CD25(high) Treg cells in patients with ankylosing spondylitis: a putative role for interleukin-10 in preventing intestinal Th17 response 291
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. 289
Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? 287
Expression of Interleukin-32 in the Inflamed Arteries of Patients With Giant Cell Arteritis 286
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity. 284
Hyaluronic acid and platelet-rich plasma, a new therapeutic alternative for scleroderma patients: A prospective open-label study 282
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 279
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18. 266
Downregulation of miRNA17-92 cluster marks Vγ9Vδ2 T cells from patients with rheumatoid arthritis 264
Associazione tra spondiloartrite e gammopatia monoclonale: tre casi clinici 261
Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis 258
Endothelial progenitor cells: Are they displaying a function in autoimmune disorders? 258
Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis 256
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis 251
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 249
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 248
IL-34 is overexpressed in the inflamed salivary glands of patients with Sjogren's syndrome and is associated with the local expansion of pro-inflammatory CD14brightCD16+ monocytes 246
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 245
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 245
ABERRANT EXPRESSION OF IL-22RA1 ON HEMATOPOIETIC CELLS AS IMMUNOLOGICALLY SIGNATURE OF PRIMARY SJOGREN’S SYNDROME AND SJOGREN-ASSOCIATED NON-HODGKIN LYMPHOMAS 244
IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. 244
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 241
Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome. 240
New insights into the pathogenesis of giant cell arteritis 240
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 239
Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients. 237
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis 236
Clinical efficacy of α4 integrin block with natalizumab in ankylosing spondylitis 234
Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjögren's syndrome 233
IL-17 polarization of MAIT cells is derived from the activation of two different pathways 231
Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitis 229
Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease 229
Atherosclerosis in female patients with rheumatoid arthritis: a two years of follow up 227
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 224
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis 223
La determinazione degli anticorpi anti-peptide ciclico citrullinato è utile nel discriminare pazienti con artrite reumatoide da quelli con poliartrite associata a tiroidite cronica autoimmune 222
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behcet's disease and deep vein thrombosis 220
Arteriosclerosi ed artrite reumatoide: ruolo della terapia biologica 216
Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients 216
Atherosclerosis in females patients with rheumatoid arthritis; a two years follow-up. 214
Brief Report: Functional Interaction of Endoplasmic Reticulum Aminopeptidase 2 and HLA–B27 Activates the Unfolded Protein Response 212
Ruolo della terapia con aspirina e con immunoglobuline endovena nella poliabortività associata a sindrome da anticorpi anti-fosfolipidi 210
Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. 209
Pro-inflammatory CX3CR1+ CD59+ TL1A+ IL-23+ monocytes are expanded in patients with Ankylosing Spondylitis and modulate ILC3 immune functions 207
Brief Report: Intestinal dysbiosis in ankylosing spondylitis 206
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 205
Atherosclerosis in female patients with rheumatoid arthritis; a two years follow-up 205
Aterosclerosi e artrite reumatoide: ruolo della twerapia biologica 201
An intense physical rehabilitation program determines pain relief and improves the global quality of life in patients with fibromyalgia 200
Disfunzione diastolica in pazienti affetti da artrite reumatoide: ruolo della terapia con anti-TNFα 199
IVIG in APS pregnancy 199
T2-mapping of the sacroiliac joints at 1.5 Tesla: a feasibility and reproducibility study 198
Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis 197
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 197
Exosomes as Intercellular Signaling Organelles Involved in Health and Disease: Basic Science and Clinical Applications 196
Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome. 196
AUTOPHAGY, BUT NOT THE UNFOLDED PROTEIN RESPONSE, REGULATES THE EXPRESSION OF IL-23 IN THEGUT OF PATIENTS WITH ANKYLOSING SPONDYLITIS AND SUBCLINICAL GUT INFLAMMATION 194
Impatto del trattamento precoce con infliximab + methotrexate ed alte dosi di prednisone (PDN) vs infliximab (IFX) + methotrexate (MTX) e basse dosi di steroide nella very early rheumatoid arthritis (VERA): contributo casistico 193
Disfunzione diastolica in pazienti affetti da artrite reumatoide:ruolo della terapia con anti-TNF 191
Pathogenesis of polymyalgia rheumatica 191
The role of the gastrointestinal tract in the pathogenesis of rheumatic diseases 190
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 190
pentoxifylline inhibits vgamma9/vdelta2 t lymphocyte activation of patients with active behçet's disease 189
Artropatia sclerodermica ed artrite reumatoide: non evidenza di overlap 186
Subclinical gut inflammation in ankylosing spondylitis 186
Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue 186
Disease-associated polymorphisms in ERAP1 do not alter endoplasmic reticulum stress in patients with ankylosing spondylitis 182
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease 182
Giant cell arteritis associated with chronic active Epstein-Barr virus infection. 181
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 181
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare 181
Rapida induzione di remissione di un caso di malattia di Vogt-Koyonagi-Harada recidivante dopo terapia con infliximab 180
Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus 180
No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study. 179
IBD e malattie reumatiche. Malattia di Crohn e spondilite anchilosante: una patogenesi comune? 177
A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease 177
Athersoclerosis in females patients with rheumatoid arthritis: a two years follow-up 176
Iniezione locale di infliximab nel trattamento della dattilite 175
Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients 175
Interleukin-9 and T helper type 9 cells in rheumatic diseases 174
Profilo citochinico ed espressione di STATS e SOCS nell’intestino di pazienti affetti da spondilite anchilosante 172
THE LEVEL OF SOLUBLE GRANZYME A IS ELEVATED IN THE PLASMA AND IN THE Vgamma9/Vdelta2 T CELL CULTURE SUPERNATANTS OF PATIENTS WITH ACTIVE BEHCET'S DISEASE 171
Micofenolato mofetil nell’alveolite sclerodermica: uno studio pilota 171
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 170
Invariant NKT cells and rheumatic disease: Focus on primary sjogren syndrome 170
β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage 170
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 169
Efficacia e sicurezza di infliximab nelle spondiloartriti indifferenziate: follow-up a 2 anni 168
Primary sjogren syndrome: Focus on innate immune cells and inflammation 168
Diastolic dysfunction in patients with rheumatoid arthritis treated with TNF blocking agents 167
The level of solubile granzyme A is elevated in the plasma and in the Vγ9/Vδ2 T cell culture supernatants of patients with active Behçet's disease. 167
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome. 167
Impatto del trattamento precoce con infliximab + methotrexate (MTX) ed alte dosi di prednisone (PDN) vs infliximab (IFX)+methotrexate (MTX) e basse dosi di steroide nella very early rheumatoid arthritis (VERA): contributo casistico 165
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis 164
Totale 22.757
Categoria #
all - tutte 110.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 110.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.881 0 382 71 76 56 111 97 143 207 287 129 322
2022/20232.675 276 470 50 251 296 375 242 211 286 37 129 52
2023/20241.187 70 181 73 81 98 247 145 68 24 47 35 118
2024/20253.351 71 220 179 264 125 140 233 220 226 318 415 940
2025/202612.342 749 603 755 1.248 1.144 1.665 1.729 1.147 946 1.348 529 479
2026/2027646 581 65 0 0 0 0 0 0 0 0 0 0
Totale 33.174